LSB (LakeShore Biopharma Co) Pre-Tax Income : $-24.21 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. LakeShore Biopharma Co's pretax income for the three months ended in Sep. 2024 was $0.00 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-24.21 Mil. LakeShore Biopharma Co's pretax margin was %.

During the past 4 years, LakeShore Biopharma Co's highest Pretax Margin was -20.10%. The lowest was -79.38%. And the median was -44.43%.

LakeShore Biopharma Co Pre-Tax Income Historical Data

The historical data trend for LakeShore Biopharma Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Pre-Tax Income Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

-26.78

-15.93

-20.95

-63.21

LakeShore Biopharma Co Quarterly Data
	Mar21	Sep21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Mar24	Sep24
Pre-Tax Income	Get a 7-Day Free Trial					-	-9.79	-14.42	-	-

Competitive Comparison of LakeShore Biopharma Co's Pre-Tax Income

For the Biotechnology subindustry, LakeShore Biopharma Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Pre-Tax Income falls into.

LakeShore Biopharma Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

LakeShore Biopharma Co's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-37.174	+	-19.877	+	-6.158	+	0	+	0.0010000000000048
	=	-63.21

LakeShore Biopharma Co's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0	+	0	+	0	+	0	+	0
	=	0.00

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.21 Mil.

LakeShore Biopharma Co (NAS:LSB) Pre-Tax Income Explanation

LakeShore Biopharma Co's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	0	/	0
	=	%

During the past 4 years, LakeShore Biopharma Co's highest Pretax Margin was -20.10%. The lowest was -79.38%. And the median was -44.43%.

LakeShore Biopharma Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

H6Z0:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.lakeshorebio.com

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.